Resveratrol in the treatment of pancreatic cancer. Ann N Y Acad Sci. 2015.
Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating FOXM1. Mol Oncol. 2018.
Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Prolif. 2018:e12514.